Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.41NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.7.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.7.13.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.7.9NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CP.1.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.3.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BA.5.2.4NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.7.3NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.19NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BA.5.2.51NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BA.5.2.11NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CY.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
XBTNNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
XBMNNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BF.34NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CP.4NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CP.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-4260.71Germany
MB.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
EG.2.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
GK.1.10ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
EG.10.1.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
GJ.1.2.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BF.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BA.2.58ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
A.27ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
BT.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.76NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.6.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BS.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BQ.1.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BN.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BL.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
CQ.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.51NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.3.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.3.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.65NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BG.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.61NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.74NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BM.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.13.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BE.1.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used